Trade Caribou Biosciences, Inc. - CRBU CFD
What is Caribou Biosciences, Inc. (CRBU)?
Caribou Biosciences, Inc. is a biotechnology company specializing in the development of gene-editing technologies based on CRISPR-Cas systems. The company focuses on creating innovative solutions for therapeutic applications, including cell therapies and genetic medicines. Caribou Biosciences conducts research and development to advance its proprietary platforms and collaborates with partners in the pharmaceutical and biotechnology sectors. Its technology aims to enable precise genetic modifications for the treatment of various diseases. The company operates within the life sciences industry, adhering to regulatory standards related to biotechnology research and product development. Caribou Biosciences contributes to the advancement of genome editing through scientific innovation and strategic collaborations.
Caribou Biosciences, Inc. Stock Price Today: Live Overview
The price today is shaped by active trading, as Caribou Biosciences, Inc. is priced at $1.97. Throughout the day, it has traded within the bounds of $1.87 and $1.98, marking a daily change of -2.5641%.
FAQ: Caribou Biosciences, Inc. (CRBU)
What is the current price of CRBU stock?
Caribou Biosciences, Inc.'s current price is $1.97.
Does CRBU pay dividends?
Caribou Biosciences, Inc. does not pay dividends.
Does CRBU have a formal corporate presence or regional headquarters in the UAE?
Caribou Biosciences, Inc. operates through partners and distributors without an official presence in the UAE.
What is CRBU best known for?
Caribou Biosciences, Inc. is most famous for its gene editing technology based on CRISPR.
What assets are typically shown together with CRBU?
Commonly shown alongside CRBU: Cooper-Standard Holdings Inc., Service Stream Limited, Anheuser-Busch InBev SA/NV
Latest shares articles



